TREATMENT PATTERNS OF ADVANCED EGFR-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) IN LATIN AMERICA

被引：0
|
作者：
Alves, J. S. [1 ]
Watanabe de Oliveira, R. [1 ]
Oliveira, D. [2 ]
Medina, Y. [3 ]
Osorio, M. [4 ]
Tabares, M. [5 ]
Tamayo, C. [6 ]
Kano, B. [7 ]
Muller Bernz, I [7 ]
机构：
[1] Janssen Cilag Farmaceut Ltda, Sao Paulo, Brazil
[2] Johnson & Johnson Med Brazil, Sao Paulo, Brazil
[3] Johnson & Johnson, Janssen Pharmaceut Co, Bogota, Cun, Colombia
[4] IQVIA, Mexico City, DF, Mexico
[5] IQVIA, Buenos Aires, DF, Argentina
[6] IQVIA, Bogota, Cun, Colombia
[7] IQVIA, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
SA56
引用
收藏
页码：S552 / S552
页数：1
相关论文
共 50 条
  • [41] Evaluation of Texture Analysis Parameters in EGFR Mutated or ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
    Bluthgen, Maria V.
    Caramella, Caroline
    Rosellini, Silvia
    Leduc, Charlotte
    Facchinetti, Francesco
    Haspinger, Eva
    Ferte, Charles
    Michiels, Stefan
    Soria, Jean C.
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S703 - S703
  • [42] Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer
    Zhang, Longfeng
    Li, Na
    Liu, Maobai
    Zheng, Bin
    Wu, Zhijuan
    Cai, Hongfu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4263 - 4270
  • [43] Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Cell Lung Cancer (NSCLC) in a University Hospital in Latin America
    Sua, Luz F.
    Rodriguez, Lisa X.
    Fernandez, Liliana
    Munoz, Carlos A.
    Restrepo, Juan G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S591 - S592
  • [44] Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study
    de Castro, J.
    Tagliaferri, P.
    de Lima, V. C. C.
    Ng, S.
    Thomas, M.
    Arunachalam, A.
    Cao, X.
    Kothari, S.
    Burke, T.
    Myeong, H.
    Grattan, A.
    Lee, D. H.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [45] Upfront Treatment With Osimertinib vs. Osimertinib and Radiotherapy for Patients With EGFR-Positive Non-Small Cell Lung Cancer Brain Metastases
    Dohm, A. E.
    Tang, J.
    Mills, M. N.
    Perez, B. A.
    Robinson, T. J.
    Creelan, B.
    Yu, H. H. M.
    Oliver, D. E.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E14 - E14
  • [46] PEMETREXED MAINTENANCE TREATMENT IN ADVANCED NON SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Megaiz, Ahlem
    Bousahba, Abdelkader
    Rabah, Aicha
    Zemmour, Amel
    Ahed-Messaoud, Malika
    Ghazli, Soumia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S588 - S589
  • [47] Treatment outcome of non-small cell lung cancer (NSCLC)-prognostic value of EGFR protein
    El-Metnawi, W
    AbdelSalam, M
    El-Nahas, T
    LUNG CANCER, 2005, 49 : S169 - S169
  • [48] Thrombosis complicating advanced non-small cell lung cancer (NSCLC) treatment.
    Aiguire, KB
    Rigas, J
    Dragnev, K
    Zacharski, L
    Virginia, B
    Disalvo, W
    Williams, I
    Carey, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 749S - 749S
  • [49] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [50] EXPERIENCE OF USING ERLOTINIB FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Kanazawa, Kenya
    Ishida, Takashi
    Suzuki, Aya
    Tachihara, Motoko
    Minemura, Hiroyuki
    Sekine, Satoko
    Oshima, Kengo
    Yokouchi, Hiroshi
    Watanabe, Kana
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1310 - S1310
12345